NDC 50090-1241

Besivance

Besifloxacin

Besivance is a Ophthalmic Suspension in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Besifloxacin.

Product ID50090-1241_354afd39-0900-4c16-be1a-e47978ab280c
NDC50090-1241
Product TypeHuman Prescription Drug
Proprietary NameBesivance
Generic NameBesifloxacin
Dosage FormSuspension
Route of AdministrationOPHTHALMIC
Marketing Start Date2009-05-28
Marketing CategoryNDA / NDA
Application NumberNDA022308
Labeler NameA-S Medication Solutions
Substance NameBESIFLOXACIN
Active Ingredient Strength6 mg/mL
Pharm ClassesQuinolone Antimicrobial [EPC],Quinolones [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 50090-1241-0

1 BOTTLE, DROPPER in 1 CARTON (50090-1241-0) > 5 mL in 1 BOTTLE, DROPPER
Marketing Start Date2014-11-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50090-1241-0 [50090124100]

Besivance SUSPENSION
Marketing CategoryNDA
Application NumberNDA022308
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2014-11-28
Marketing End Date2019-12-31

Drug Details

Active Ingredients

IngredientStrength
BESIFLOXACIN6 mg/mL

OpenFDA Data

SPL SET ID:b111b1ab-10b0-4378-8aef-e51d5274306c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 850309
  • 850305
  • Pharmacological Class

    • Quinolone Antimicrobial [EPC]
    • Quinolones [CS]

    NDC Crossover Matching brand name "Besivance" or generic name "Besifloxacin"

    NDCBrand NameGeneric Name
    24208-446BesivanceBesifloxacin
    50090-1241BesivanceBesifloxacin

    Trademark Results [Besivance]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    BESIVANCE
    BESIVANCE
    77632895 3796795 Live/Registered
    BAUSCH & LOMB INCORPORATED
    2008-12-15

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.